Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities

Head and neck squamous cell carcinoma (HNSCC) belongs to the most frequent cancer subtypes in the world. Mutations due to genetic and chromosomal instability, syndromes such as Fanconi anemia and the Bloom syndrome, environmental risk factors such as tobacco smoking, alcohol and human papillomavirus...

Full description

Bibliographic Details
Main Authors: Zisis Vasileios, Venou Maria, Poulopoulos Athanasios, Andreadis Dimitrios
Format: Article
Language:English
Published: Balkan Stomatological Society 2021-07-01
Series:Balkan Journal of Dental Medicine
Subjects:
Online Access:https://doi.org/10.2478/bjdm-2021-0012
_version_ 1818200083365101568
author Zisis Vasileios
Venou Maria
Poulopoulos Athanasios
Andreadis Dimitrios
author_facet Zisis Vasileios
Venou Maria
Poulopoulos Athanasios
Andreadis Dimitrios
author_sort Zisis Vasileios
collection DOAJ
description Head and neck squamous cell carcinoma (HNSCC) belongs to the most frequent cancer subtypes in the world. Mutations due to genetic and chromosomal instability, syndromes such as Fanconi anemia and the Bloom syndrome, environmental risk factors such as tobacco smoking, alcohol and human papillomavirus infection (HPV) subtypes 16,18,31,33,35,52,58 are implicated in its pathogenesis. The HNSCC belongs to the solid tumors of epithelial origin and consists of stromal, inflammatory, cancer cells and most importantly a fraction of them, the cancer stem cells (CSCs). The identification of the CSCs through their biomarkers such as CD44, CD10, CD166, CD133, CD271, ALDH, Oct4, Nanog, Sox2 and Bmi1, the maintenance of their subpopulation through epithelial to mesenchymal transition, the role of HPV infection regarding their prognosis and of their microenvironment regarding their resistance to therapy, all constitute key elements that must be taken thoroughly into consideration in order to develop an effective targeted therapy. There are already therapies in place targeting specific related biomarkers, important biochemical pathways and growth factors. The aim of this literature review is to illustrate the treatment modalities available against the cancer stem cells of head and neck squamous cell carcinoma.
first_indexed 2024-12-12T02:32:01Z
format Article
id doaj.art-6ac9edcdfafc4aeb945a056c04fae782
institution Directory Open Access Journal
issn 2335-0245
language English
last_indexed 2024-12-12T02:32:01Z
publishDate 2021-07-01
publisher Balkan Stomatological Society
record_format Article
series Balkan Journal of Dental Medicine
spelling doaj.art-6ac9edcdfafc4aeb945a056c04fae7822022-12-22T00:41:23ZengBalkan Stomatological SocietyBalkan Journal of Dental Medicine2335-02452021-07-01252737910.2478/bjdm-2021-0012Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment ModalitiesZisis Vasileios0Venou Maria1Poulopoulos Athanasios2Andreadis Dimitrios3Department of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, GreeceDepartment of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, GreeceDepartment of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, GreeceDepartment of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, GreeceHead and neck squamous cell carcinoma (HNSCC) belongs to the most frequent cancer subtypes in the world. Mutations due to genetic and chromosomal instability, syndromes such as Fanconi anemia and the Bloom syndrome, environmental risk factors such as tobacco smoking, alcohol and human papillomavirus infection (HPV) subtypes 16,18,31,33,35,52,58 are implicated in its pathogenesis. The HNSCC belongs to the solid tumors of epithelial origin and consists of stromal, inflammatory, cancer cells and most importantly a fraction of them, the cancer stem cells (CSCs). The identification of the CSCs through their biomarkers such as CD44, CD10, CD166, CD133, CD271, ALDH, Oct4, Nanog, Sox2 and Bmi1, the maintenance of their subpopulation through epithelial to mesenchymal transition, the role of HPV infection regarding their prognosis and of their microenvironment regarding their resistance to therapy, all constitute key elements that must be taken thoroughly into consideration in order to develop an effective targeted therapy. There are already therapies in place targeting specific related biomarkers, important biochemical pathways and growth factors. The aim of this literature review is to illustrate the treatment modalities available against the cancer stem cells of head and neck squamous cell carcinoma.https://doi.org/10.2478/bjdm-2021-0012cancer stem cellsoral canceroral cancer stem cellshead and neck cancerhpv and cancercancer stem cells treatment
spellingShingle Zisis Vasileios
Venou Maria
Poulopoulos Athanasios
Andreadis Dimitrios
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities
Balkan Journal of Dental Medicine
cancer stem cells
oral cancer
oral cancer stem cells
head and neck cancer
hpv and cancer
cancer stem cells treatment
title Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities
title_full Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities
title_fullStr Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities
title_full_unstemmed Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities
title_short Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities
title_sort cancer stem cells in head and neck squamous cell carcinoma treatment modalities
topic cancer stem cells
oral cancer
oral cancer stem cells
head and neck cancer
hpv and cancer
cancer stem cells treatment
url https://doi.org/10.2478/bjdm-2021-0012
work_keys_str_mv AT zisisvasileios cancerstemcellsinheadandnecksquamouscellcarcinomatreatmentmodalities
AT venoumaria cancerstemcellsinheadandnecksquamouscellcarcinomatreatmentmodalities
AT poulopoulosathanasios cancerstemcellsinheadandnecksquamouscellcarcinomatreatmentmodalities
AT andreadisdimitrios cancerstemcellsinheadandnecksquamouscellcarcinomatreatmentmodalities